SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-07-000082
Filing Date
2007-02-14
Accepted
2007-02-14 15:00:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 13, 2007 cell13ga-021307.htm SC 13G/A 47259
  Complete submission text file 0001013594-07-000082.txt   49147
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 07618911
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 CHURCH STREET, SKANDIA HOUSE HAMILTON D0 HM11
Business Address 18 CHURCH STREET, SKANDIA HOUSE HAMILTON D0 HM11 441-294-3202
Linden Capital L.P. (Filed by) CIK: 0001349339 (see all company filings)

IRS No.: 980430338 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A